About Nectar Lifesciences
Nectar Lifesciences is a company based in Chandigarh (India) founded in 1995.. Nectar Lifesciences has raised $46.85 million across 1 funding round from investors including NSR Partners. The company has 1,790 employees as of March 31, 2024. Nectar Lifesciences offers products and services including Cephalosporin APIs, Formulations, and Empty Hard Gelatin Capsules.
- Headquarter Chandigarh, India
- Employees 1790 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nectar Lifesciences Ltd.
-
Annual Revenue
$195.44 M (USD)-0.74as on Mar 31, 2024
-
Net Profit
$-13.32 M (USD)-2375.9as on Mar 31, 2024
-
EBITDA
$-2.89 M (USD)-116.03as on Mar 31, 2024
-
Total Equity Funding
$46.85 M (USD)
in 1 rounds
-
Latest Funding Round
$46.85 M (USD), Private Equity Round
Mar 10, 2010
- Investors
-
Employee Count
1790
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nectar Lifesciences
Nectar Lifesciences is a publicly listed company on the NSE with ticker symbol NECLIFE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Nectar Lifesciences
Nectar Lifesciences offers a comprehensive portfolio of products and services, including Cephalosporin APIs, Formulations, and Empty Hard Gelatin Capsules. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactures antibiotics like Cefixime for global healthcare needs.
Produces tablets, capsules, and injectables for pharmaceutical use.
Provides capsules for formulation in pharmaceutical applications.
Unlock access to complete
Funding Insights of Nectar Lifesciences
Nectar Lifesciences has successfully raised a total of $46.85M through 1 strategic funding round. The most recent funding activity was a Private Equity Round round of $46.85 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $46.9M
-
First Round
First Round
(10 Mar 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2010 | Amount | Private Equity Round - Nectar Lifesciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nectar Lifesciences
Nectar Lifesciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NSR Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage private equity investments are pursued across sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nectar Lifesciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nectar Lifesciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nectar Lifesciences Comparisons
Competitors of Nectar Lifesciences
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nectar Lifesciences
Frequently Asked Questions about Nectar Lifesciences
When was Nectar Lifesciences founded?
Nectar Lifesciences was founded in 1995 and raised its 1st funding round 15 years after it was founded.
Where is Nectar Lifesciences located?
Nectar Lifesciences is headquartered in Chandigarh, India.
Who is the current CEO of Nectar Lifesciences?
Amit Chadah is the current CEO of Nectar Lifesciences.
Is Nectar Lifesciences a funded company?
Nectar Lifesciences is a funded company, having raised a total of $46.85M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $46.85M, raised on Mar 10, 2010.
How many employees does Nectar Lifesciences have?
As of Mar 31, 2024, the latest employee count at Nectar Lifesciences is 1,790.
What is the annual revenue of Nectar Lifesciences?
Annual revenue of Nectar Lifesciences is $195.44M as on Mar 31, 2024.
What does Nectar Lifesciences do?
Nectar Lifesciences was founded in 1995 and is headquartered in Chandigarh, India. Operations in the pharmaceutical sector involve the production of cephalosporin active pharmaceutical ingredients and generic formulations. Additional offerings include contract research and manufacturing services, hard gelatin capsules, in vitro diagnostics, and natural extracts such as menthol and mint derivatives along with guar gum. Focus remains on core pharmaceutical manufacturing and related services.
What products or services does Nectar Lifesciences offer?
Nectar Lifesciences offers Cephalosporin APIs, Formulations, and Empty Hard Gelatin Capsules.
Is Nectar Lifesciences publicly traded?
Yes, Nectar Lifesciences is publicly traded on NSE under the ticker symbol NECLIFE.
Who are Nectar Lifesciences's investors?
Nectar Lifesciences has 1 investor. Key investors include NSR Partners.
What is Nectar Lifesciences's ticker symbol?
The ticker symbol of Nectar Lifesciences is NECLIFE on NSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.